Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA)

CUSIP: 640979100

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+12,138,630
Put/Call ratio
8.9%
SEC-reported price per share
$1.79
Number of holders
101
Value change
+$21,661,237
Number of buys
55
Open additional details 1 more signal available
Number of sells
34
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
186,788,806

Security key

640979100

Report period

Q4 2025

Institutions

101

Top holders

10

Ownership snapshot

Top reported holders of NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Paul L. Berns
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
27 Oct 2025
13D/G 3/4/5 13F Lead comparable stake: 5.1% 13D/G row: Paul L. Berns Showing 1-6 of 15 holder rows.

Quick read

Paul L. Berns leads the comparable SEC ownership view at 5.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Paul L. Berns's linked filing trail.
Comparable ownership Top 5
Paul L. Berns 5.1%
FMR LLC 2.2%
ARCH Venture Partners X, LLC 18%
ARCH Venture Partners XII, LLC 18%
SOFTBANK GROUP CORP. 3.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Paul L. Berns
13D/G
5.1%
$6,334,229
8,226,272 shares
$0 31 Dec 2024
FMR LLC
3/4/5 13D/G 13F
Other* · Company
2.2%
from 13D/G
$67,379,749
5,624,353 shares
19 Sep 2023
ARCH Venture Partners X, LLC
3/4/5
10%+ Owner
18%
$66,380,119
33,847,838 shares
+$4,999,977 27 Oct 2025
ARCH Venture Partners XII, LLC
3/4/5
10%+ Owner
18%
$66,380,119
33,847,838 shares
+$4,999,977 27 Oct 2025
SOFTBANK GROUP CORP.
13F
Company
13F
3.5%
$11,904,966
6,541,190 shares
30 Sep 2025
MIC Capital Management UK LLP
13F
Company
13F
2.4%
$8,118,474
4,460,700 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
101
Shares
62,936,237
Rows available
101
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
91
Q4 2025 holders
101
Holder diff
10
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .